Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Oncology
New research in the area of oncology detailed
April 19th, 2005
Investigators in Japan have published new oncology data. Study 1: Angiotensin type 1a receptor signals trigger tumor-associated angiogenesis. According to recent research published in the journal Carcinogenesis, "angiotensin II is a multi-functional bioactive peptide and recent reports have suggested that angiotensin II is a proangiogenic growth factor. A retrospective cohort study revealed that angiotensin converting enzyme inhibitors decreased cancer risk, however, the precise mechanism is unknown. We hypothesized that endogenous angiotensin II plays a crucial role in tumor-associated angiogenesis." "Tumors implanted in...
Source: Cancer Weekly (2005-04-19)
|
